CODEXIS INC. - COMMON STOCK

Codexis and Molecular Assemblies Announce Results of First Collaboration on a Proprietary High Performing DNA Polymerase to Supercharge Fully Enzymatic DNA Synthesis

12 4 2022 07:00:01 提供 Nasdaq GlobeNewswire

Codexis to Participate in the Cowen 42nd Annual Health Care Conference

01 3 2022 15:05:01 提供 Nasdaq GlobeNewswire

Codexis Reports Fourth Quarter and Fiscal Year 2021 Financial Results

24 2 2022 15:05:01 提供 Nasdaq GlobeNewswire

Codexis to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 24

10 2 2022 15:05:00 提供 Nasdaq GlobeNewswire

Codexis Announces FDA Orphan Drug and Rare Pediatric Disease Designations for CDX 6512 for the Treatment of Homocystinuria

24 1 2022 07:00:00 提供 Nasdaq GlobeNewswire

Codexis to Participate in the H.C. Wainwright Virtual BioConnect Conference

05 1 2022 07:00:02 提供 Nasdaq GlobeNewswire

Codexis Launches Codex® HiTemp Reverse Transcriptase to Address Key Challenges in One-Step Assays for RNA Detection in PCR Testing, including COVID-19 Testing

15 12 2021 07:00:01 提供 Nasdaq GlobeNewswire

Codexis Presents Pre-Clinical Data Highlighting its Programs in Homocystinuria and Maple Syrup Urine Disease at ICIEM 2021

22 11 2021 07:00:02 提供 Nasdaq GlobeNewswire

Codexis to Participate in Upcoming Virtual Healthcare Conferences

19 11 2021 07:00:00 提供 Nasdaq GlobeNewswire

Codexis Appoints Two New Senior Leaders for Human Resources and Corporate Development

15 11 2021 07:00:03 提供 Nasdaq GlobeNewswire

Codexis to Present Data Highlighting Two New Therapeutic Discovery Programs at the 14th International Congress of Inborn Errors of Metabolism 2021

15 11 2021 07:00:03 提供 Nasdaq GlobeNewswire

Codexis to Participate in Upcoming Virtual Healthcare Conferences

09 11 2021 15:05:00 提供 Nasdaq GlobeNewswire

Codexis Reports Third Quarter 2021 Financial Results

04 11 2021 15:05:02 提供 Nasdaq GlobeNewswire

The SynBio Innovation Accelerator, a Collaboration between Codexis and Casdin Capital, Enables $10 million Investment in Molecular Assemblies, Inc.

04 11 2021 07:00:01 提供 Nasdaq GlobeNewswire

Codexis and Nestlé Health Science Initiate a Phase 1 Clinical Trial of CDX-7108 for Exocrine Pancreatic Insufficiency

03 11 2021 15:05:00 提供 Nasdaq GlobeNewswire

Codexis to Report Third Quarter 2021 Financial Results on November 4

21 10 2021 15:05:00 提供 Nasdaq GlobeNewswire

Codexis, Almelo and RC2 Announce a Tri-Party Collaboration for the Enzymatic Production of Low Cost Sitagliptin API for the Generic Market, Including a License to Codexis Enzyme Technology in India

18 10 2021 07:00:01 提供 Nasdaq GlobeNewswire

Codexis and Merck Amend and Extend Supply Agreement for Enzyme Used in Manufacture of Sitagliptin

09 9 2021 15:05:00 提供 Nasdaq GlobeNewswire

Codexis to Participate in Upcoming Virtual Healthcare Conferences

07 9 2021 15:05:00 提供 Nasdaq GlobeNewswire

Codexis Confirms Receipt of Follow-on Orders for Proprietary Enzyme Product from Undisclosed Global Pharmaceutical Company

25 8 2021 15:05:00 提供 Nasdaq GlobeNewswire